Member Info for AquaeSulis01

Apple's move to 5G Technology has got to be good for Fedwireless

That hockey stick is looking more like a lacrosse stick now

Doesn't look the most fertile farm in the world :)

https://www.proactiveinvestors.co.uk/companies/news/931188/optibiotix-health-shares-lifted-by-launch-of-meal-replacement-products-down-under-931188.html

https://www.yorkshirepost.co.uk/business/consumer/yorkshire-firm-launches-weight-loss-bars-and-shakes-australia-and-new-zealand-2999987

Agree, having OptiBiome as part of a weight management meal replacement package is a major step forward and has finally tempted me in to buy.

https://www.valuethemarkets.com/2020/10/09/the-silver-lining-why-silver-looks-to-be-an-exciting-prospect-for-the-year/

The adaptability of silver
What separates the two metals, and perhaps makes silver a more viable asset, is that gold’s value comes mostly from jewellery and as a currency proxy. While some of silver’s value is also tied up in jewellery, half of all silver is purchased for industrial use.
These uses include the production of solar panels and batteries – which is a giant green tick for silver’s long-term price – an assortment of electronics, and as an antibacterial element. The use in solar panels alone is a good omen; the market for sustainability is expected to triple in the next few years, meaning silver will be in increasingly high demand.
How high can it go?
In the face of these recent price increases, FXEmpire projects an incredible target of silver from anywhere between £105 ($135) and £166 ($213) per ounce in the next six months, if not even higher. That’s a ridiculous rally of more than 700% – a once-in-a-lifetime occurrence.

More conservatively, GoldSilver predicted back in June a 2020 high of £15.60 ($20) per ounce with no crisis, and £19.49 ($25) with crisis. Both of which the stock has surpassed. They did predict, though, a potential five-year high of £80-£116 ($100-$150).

These are two contrasting predictions, but the general consensus is an overall increase in silver’s future.

Nice to see the director buys

The missing link :)

Up to two dozen people in Britain could be deliberately infected with a weakened form of coronavirus as part of a trial to develop a vaccine against Covid-19.

New York-based company Codagenix plans to begin experiments of its vaccine in London by the end of the year.

The jab will be of a type called a live attenuated vaccine, meaning people will be given a genetically-modified version of the coronavirus that is weaker than the real thing but still infectious.

https://www.dailymail.co.uk/news/article-8781671/Scientists-develop-live-coronavirus-vaccine-UK-trial.html

The reason we have a muted response to an excellent RNS is I suspect, that for whatever reason (maybe to re-balance their portfolios, HSBC and Sangrove are II sellers into the raise. Once they have cleared, then this should start to reflect something like true value

Ironman, I think you are confusing the company valuation with the Market Capitalisation, the latter is merely the sp * number of shares so if as you acknowledge the Immutex drives the sp up in the short term, then the market cap will also increase, simples

Taken an opposite view to you DaddyAIM, I think the RNS was very positive when contrasted to the severe drop already built into the share price. The outlook looks bright and so it seems like a good idea to buy in, take the dividend payments and wait for a sp recovery in the mid-term

https://www.***************************/open-orphan-dual-business-firing-on-all-four-cylinders-interview/412862789

Well if remdesivir can make a 74 year old overweight male who had developed a fever well again in a short space of time, augers well for the anticipated authorisation of Human Challenge Studies for fit young adults.

Donald Trump's team of doctors says he is doing well after his Covid-19 diagnosis and could be discharged as early as Monday.

Dr Brian Garibaldi, a specialist in pulmonary critical care, said Mr Trump received a second dose of the experimental drug remdesivir along with a first dose of dexamethasone on Saturday and isn't showing any side effects "that we can tell."

Speaking to reporters on Sunday afternoon, that the US president is "up and well" and the plan was to have him "out of bed" on Sunday as much as possible, and could potentially return to the White House to continue his five-day course of remdesivir.

CF acquired the additional shares at the Jan 2020 placing. The 8.6% holding was diluted following the fundraising in May

4,918,030 45,965,011 8.6 %

Quite agree Blah. On a separate note, do Board Members think that a speedy recovery of Donald Trump, aided by Remdesivir, will act as a final catalyst to Human Challenge Studies for covid19 whilst his failure to recover could delay a decision?

katoro gold update also included "Louis Coetzee, Chairman of Katoro Gold plc, commented: "I am very pleased that we are able to announce the mobilisation of the first exploration drilling program at Haneti. We believe that Haneti holds significant potential to host a world class nickel deposit within a previously identified 80km long ultramafic complex. Previous exploration work in this complex delivered nickel values as high as 13.6% and 2.33 g/t combined platinum and palladium.""

830 beds but you are asking the wrong question, it is how many high level isolation beds are there and the answer is The Royal Free Hospital has a total complement of 34 intensive care beds, all of which can
provide a level 3 facility.

Always useful to compare with the previous update; 7th July. At that point the sp was 27.55 with a net debt of £413, prompting Andrew Shepherd-Barron, analyst at Peel Hunt, to state: "Trading in the first quarter has been better than expected. We upgrade full-year 2021 profits before tax from €5m to €10m, and leave 2022 and 2023 unchanged at €42m and €63.6m respectively."
Peel Hunt, which had a 'buy' recommendation on the stock, left its price target of 49.0p unchanged. But Shepherd-Barron added: "There is substantial upside beyond this if expectations begin to be delivered."

Today the net debt has fallen further to £407M reflecting the further progress made and yet the sp even now languishes some 20% below the July 7th levels demonstrating the considerable upside in the short term

Dividend decision

The Board has decided to pay an additional dividend of 4.4p per share, representing the deferred final dividend from FY20.

https://www.investorschronicle.co.uk/company-news/2020/09/30/qinetiq-beats-expectations-and-reinstates-dividend/